STOCK TITAN

Laser Photonics Announces Exercise of Warrants for $4 Million Gross Proceeds

(Very High)
(Positive)
Tags

Laser Photonics (NASDAQ:LASE) announced definitive agreements for immediate exercise of outstanding warrants to purchase up to 5,715,085 common shares at an exercise price of $0.70, generating approximately $4.0 million gross proceeds prior to fees and expenses.

In exchange, the company will issue unregistered Series A-5 warrants for up to 4,742,860 shares and Series A-6 warrants for up to 6,687,310 shares at a $0.975 exercise price; closing expected on or about April 28, 2026. Proceeds are for working capital and general corporate purposes.

Loading...
Loading translation...

Positive

  • Gross proceeds of approximately $4.0 million
  • Shares issuable are registered on Form S-1 (No. 333-292932)
  • Exclusive placement agent: H.C. Wainwright & Co.

Negative

  • Potential dilution: up to 5,715,085 existing-warrant shares upon exercise
  • New unregistered warrants cover up to 11,430,170 additional shares combined
  • New warrants require stockholder approval and resale registration before public sales

News Market Reaction – LASE

-19.38%
26 alerts
-19.38% Session close to close
-39.1% Trough in 1 hr 31 min
$31.78M Market Cap
0.9x Rel. Volume

In the Apr 27 session, LASE declined 19.38%, reflecting a significant negative market reaction. Argus tracked a trough of -39.1% from its starting point during tracking. Our momentum scanner triggered 26 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock dropped -19.4% in the session following this news. A negative reaction despite the cash in...
Analysis

The stock dropped -19.4% in the session following this news. A negative reaction despite the cash inflow of about $4 million would fit the pattern seen in prior offerings, where similar financings averaged roughly -21.05% over one day. The new Series A-5 and A-6 warrants add additional equity overhang, which has frequently pressured LASE shares around capital-raising events. Future trading often hinged on how efficiently the raised funds supported growth versus the market’s focus on dilution risk.

Key Figures

Gross proceeds: $4 million Warrants exercised: 5,715,085 shares Exercise price: $0.70 per share +5 more
8 metrics
Gross proceeds $4 million Immediate exercise of certain outstanding warrants
Warrants exercised 5,715,085 shares Outstanding warrants originally issued February 2026
Exercise price $0.70 per share Price for exercised February 2026 warrants
New Series A-5 warrants 4,742,860 shares Unregistered warrants issued as inducement
New Series A-6 warrants 6,687,310 shares Unregistered warrants issued as inducement
New warrant exercise price $0.975 per share Exercise price for Series A-5 and A-6 warrants
Series A-5 term Five years Expires five years after later of approval and resale effectiveness
Series A-6 term Twenty-four months Expires 24 months after later of approval and resale effectiveness

Previous Offering Reports

3 past events · Latest: Mar 17 (Negative)
Same Type Pattern 3 events
Date Event Sentiment 24h Move Catalyst
Mar 17 Warrant exercise closing Negative -6.8% Closed cash exercise of warrants raising about $1.5M with new warrants issued.
Mar 16 Warrant inducement deal Negative -18.0% Announced immediate warrant exercise for ~$1.5M gross and issuance of new A-3/A-4 warrants.
Feb 06 Public equity offering Negative -38.4% Priced $5.0M public offering with A-1 and A-2 warrants at $0.70 per unit.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior offering headlines for LASE have been followed by consistent negative moves, averaging -21.05%, indicating equity financings and warrant inducements have historically weighed on the stock.

Recent Company History

Over recent months, Laser Photonics has repeatedly accessed equity markets via offerings and warrant inducements. A February 2026 public offering raised about $5.0M at $0.70 per unit with attached warrants, followed by March warrant exercises and inducement deals that generated about $1.5M in gross proceeds at a reduced $1.08 exercise price. Each of these financing-related announcements saw negative one-day price reactions, providing context for the latest $4M warrant exercise.

Key Terms

warrants, placement agent, form s-1, registration statement, +2 more
6 terms
warrants financial
"exercise of certain outstanding warrants to purchase up to an aggregate of 5,715,085 shares"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
View in glossary
placement agent financial
"H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering."
A placement agent is a professional or firm that helps organizations raise money from investors, such as individuals, institutions, or funds. They act like matchmakers, connecting those seeking investments with the right investors and guiding the process to ensure successful funding. For investors, they can provide access to exclusive opportunities and help navigate complex fundraising efforts.
form s-1 regulatory
"registered pursuant to an effective registration statement on Form S-1 (No. 333-292932)."
A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.
registration statement regulatory
"The Company has agreed to file a registration statement with the SEC covering the resale"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
resale registration statement regulatory
"file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement")."
A resale registration statement is a document filed with regulators that allows existing shareholders to sell their shares to the public. It provides the necessary legal approval and information for these shares to be resold on the market, helping to increase the availability of shares for trading. For investors, it signals that shares held by current owners can be offered for sale, potentially affecting share prices and market liquidity.
private placement financial
"The new warrants described above were offered in a private placement pursuant to an applicable exemption"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ORLANDO, FL / ACCESS Newswire / April 27, 2026 / Laser Photonics Corporation (NASDAQ:LASE) (the "Company"), a global leader in laser systems for industrial and defense applications, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 5,715,085 shares of common stock of the Company originally issued in February 2026, having an exercise price of $0.70 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-292932). The gross proceeds to the Company from the exercise of the warrants are expected to be approximately $4 million, prior to deducting placement agent fees and estimated offering expenses.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

In consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered Series A-5 warrants to purchase up to 4,742,860 shares of common stock and new unregistered Series A-6 warrants to purchase up to 6,687,310 shares of common stock. The new warrants will have an exercise price of $0.975 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the new warrants. The Series A-5 new warrants will expire five years after the later of (i) the date of stockholder approval and (ii) the effective date of the Resale Registration Statement (as defined below) and the Series A-6 new warrants will expire twenty-four months after the later of (x) the date of stockholder approval and (y) the effective date of the Resale Registration Statement.

The offering is expected to close on or about April 28, 2026, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "1933 Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement").

This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Laser Photonics Corporation

Laser Photonics Corporation (NASDAQ:LASE) is a global leader in laser systems for industrial and defense applications. The Company develops and manufactures advanced laser technologies used in cleaning, surface preparation, and precision material processing across demanding operating environments. Laser Photonics serves a broad range of end markets, including defense and government, aerospace, energy, maritime, automotive, and advanced manufacturing. Through a combination of internal development, strategic acquisitions, and partnerships, the Company continues to expand its product portfolio and address new applications where performance, efficiency, and environmental considerations are critical. For more information, please visit https://laserphotonics.com.

Cautionary Note Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering, the receipt of stockholder approval and the intended use of net proceeds from the offering. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption "Risk Factors" in our Form 10-K for the fiscal year ended December 31, 2025. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.

Investor Relations Contact:
Lucas A. Zimmerman & Ian Scargill
MZ Group - MZ North America
(262) 357-2918
LASE@mzgroup.us
www.mzgroup.us

SOURCE: Laser Photonics Corp.



View the original press release on ACCESS Newswire

FAQ

What did Laser Photonics (LASE) announce on April 27, 2026 about warrants and proceeds?

The company announced immediate exercise of warrants for up to 5,715,085 shares generating ~$4.0 million gross. According to the company, the exercised warrants have a $0.70 price and closing is expected on or about April 28, 2026.

What are the terms of the new Series A-5 and A-6 warrants issued by Laser Photonics (LASE)?

The company will issue Series A-5 and A-6 warrants exercisable at $0.975 per share with differing expirations. According to the company, A-5 covers 4,742,860 shares and A-6 covers 6,687,310 shares, subject to stockholder approval and registration timing.

When will the offering close and how will Laser Photonics (LASE) use the net proceeds?

The offering is expected to close on or about April 28, 2026, subject to customary conditions. According to the company, net proceeds are intended for working capital and general corporate purposes.

Are the new warrants and shares immediately tradable after issuance for Laser Photonics (LASE)?

No; the new warrants and resulting shares are unregistered and not immediately tradable in the U.S. According to the company, a resale registration statement will be filed with the SEC to permit resale upon effectiveness and stockholder approval.

Who is acting as placement agent for the Laser Photonics (LASE) warrant exercise offering?

H.C. Wainwright & Co. is the exclusive placement agent for the transaction. According to the company, placement agent fees and offering expenses will be deducted from the gross proceeds of approximately $4.0 million.